PREFER - Why, when and how to assess and use patient preferences in medical product decision-making

Part of EU Open Research Repository
Published December 2, 2021 | Version v1
Other Open

Identification of educational and psychological feature methods

Creators

  • 1. Uppsala University
  • 2. Merck Sharpe & Dohme
  • 3. European Institute of Oncology
  • 4. Mindbytes

Description

This report describes the main activities or subtasks of PREFER work package 2, task 2.5 (WP2.5). These activities were undertaken to address the specific aims of WP2.5 to identify, describe and assess the clinical feasibility of (1) using different ways to communicate risk, (2) educate patients (with a focus on scenario-based interactive tools (SBITs), and (3) profile psychological variables that can affect the construction, elicitation, and interpretation of patient preferences. The first step in WP2.5 was to perform a review in each of the 3 areas of interest. Once the literature review of psychological variables and educational tools was completed, motivational factors for selecting psychological constructs to measure and educational components of a preference study were described, and appraisal criteria were developed for selecting specific psychological measurement instruments and educational features.

Files

115966_PREFER_Deliverable_2.5_final_revised.pdf

Files (7.9 MB)

Additional details

Funding

European Commission
PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966